# A Multiple-Dose Study of LY3502970 in Healthy Participants

> **NCT05110794** · PHASE1 · COMPLETED · sponsor: **Eli Lilly and Company** · enrollment: 33 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** LY3502970

## Key facts

- **NCT ID:** NCT05110794
- **Lead sponsor:** Eli Lilly and Company
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-11-05
- **Primary completion:** 2022-02-10
- **Final completion:** 2022-02-10
- **Target enrollment:** 33 (ACTUAL)
- **Last updated:** 2022-06-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05110794

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05110794, "A Multiple-Dose Study of LY3502970 in Healthy Participants". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT05110794. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*